| Financial Year |
March 31 2023 |
| Monetary Funds |
2,496,822,036.98 |
| Held-for-trading Financial Assets |
538,535,694.44 |
| Notes Receivable |
-- |
| Accounts Receivable |
175,170,104.21 |
| Advances to Suppliers |
27,832,295.63 |
| Other Receivables |
150,520,355.86 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
986,809,255.40 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
456,342,888.08 |
| Other Current Assets |
131,166,001.37 |
| Total Current Assets |
4,964,931,060.86 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
611,750,588.12 |
| Long-term Equity Investment |
599,007,506.43 |
| Investment Properties |
7,462,621,970.96 |
| Fixed Assetes |
321,405,804.67 |
| Under-construction Projects |
1,551,429.82 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
40,200,381.19 |
| R&D expenses |
-- |
| Goodwill |
35,755,690.12 |
| Long-Term Deferred and Prepaid Expenses |
11,766,885.38 |
| Deferred Income Tax Assets |
172,106,817.12 |
| Other Non-Current Assets |
558,698.09 |
| Sub-Total of Non-Current Assets |
9,631,164,607.67 |
| Total Assets |
14,596,095,668.53 |
| Short-Term Loans |
430,396,113.89 |
| Trading Financial liabilities |
-- |
| Notes Payable |
574,580,628.77 |
| Accounts Payable |
317,490,522.57 |
| Accounts Received In Advance |
309,781,453.09 |
| Employee Compensation Payable |
16,895,248.50 |
| Taxes Payable |
129,434,718.29 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
582,410,036.44 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
677,713,630.13 |
| Other Current Liabilities |
1,125,424,065.48 |
| Sub-Total of Current Liabilities |
4,352,853,416.72 |
| Long-term Loans |
142,352,149.90 |
| Bonds Payable |
404,075,479.45 |
| Long-Term Accounts Payable |
90,064,952.84 |
| Special Payable |
-- |
| Estimatied Liabilities |
31,175,455.18 |
| Deferred Income Tax Liabilities |
23,514,732.68 |
| Other Non-Current Liabilities |
311,152,446.00 |
| Sub-Total of Non-Current Liabilities |
1,637,664,648.59 |
| Total Liabilities |
5,990,518,065.31 |
| Paid-In Capital(Or Share Stock) |
1,282,616,960.00 |
| Capital Surplus |
1,620,229,785.52 |
| Surplus Reserve |
458,206,953.82 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
5,012,252,219.86 |
| Minority Stockholder's Interest |
232,271,684.02 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,373,305,919.20 |
| Owner's Equity（Stockholder's Equity） |
8,605,577,603.22 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
14,596,095,668.53 |
